Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).
Montalescot G, Bal-dit-Sollier C, Chibedi D, Collet JP, Soulat T, Dalby M, Choussat R, Cohen A, Slama M, Steg PG, Dubois-Randé JL, Metzger JP, Tarragano F, Guermonprez JL, Drouet L; ARMADA Investigators. Montalescot G, et al. Among authors: tarragano f. Am J Cardiol. 2003 Apr 15;91(8):925-30. doi: 10.1016/s0002-9149(03)00105-x. Am J Cardiol. 2003. PMID: 12686329 Clinical Trial.
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up.
Bonnefoy E, Steg PG, Boutitie F, Dubien PY, Lapostolle F, Roncalli J, Dissait F, Vanzetto G, Leizorowicz A, Kirkorian G; CAPTIM Investigators; Mercier C, McFadden EP, Touboul P. Bonnefoy E, et al. Eur Heart J. 2009 Jul;30(13):1598-606. doi: 10.1093/eurheartj/ehp156. Epub 2009 May 8. Eur Heart J. 2009. PMID: 19429632 Clinical Trial.
Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry.
Cayla G, Koning R, Fajadet J, Sainsous J, Carrié D, Elhadad S, Tarragano F, Lefévre T, Ranc S, Ghostine S, Garot P, Marco F, Maillard L, Motreff P, Le Breton H; FRANCE ABSORB investigators. Cayla G, et al. Among authors: tarragano f. Arch Cardiovasc Dis. 2019 Feb;112(2):113-123. doi: 10.1016/j.acvd.2018.09.007. Epub 2019 Jan 7. Arch Cardiovasc Dis. 2019. PMID: 30630761 Free article.
[Rotational coronary angiography].
Smida W, Sidéris G, Stratiev V, Logeart D, Ouadhour A, Tarragano F, Bonnevie L, Azancot I, Henry P. Smida W, et al. Among authors: tarragano f. Arch Mal Coeur Vaiss. 2007 Nov;100(11):895-900. Arch Mal Coeur Vaiss. 2007. PMID: 18209689 Clinical Trial. French.
Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
Lhermusier T, Carrie D, Cayla G, Fajadet J, Sainsous J, Elhadad S, Tarragano F, Chevalier B, Ranc S, Curinier C, Le Breton H, Koning R; FRANCE ABSORB Investigators. Lhermusier T, et al. Among authors: tarragano f. Catheter Cardiovasc Interv. 2021 Sep;98(3):511-519. doi: 10.1002/ccd.29369. Epub 2020 Nov 19. Catheter Cardiovasc Interv. 2021. PMID: 33211387
Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry.
Landolff Q, Lefèvre T, Fajadet J, Sainsous J, Lhermusier T, Elhadad S, Tarragano F, Ranc S, Ghostine S, Cayla G, Marco F, Garot P, Maillard L, Motreff P, Delarche N, De Labriolle A, Pansieri M, Morelle JF, Cazaux P, Moulichon ME, Chopat P, Angoulvant D, Bataille V, Le Breton H, Koning R; FRANCE ABSORB investigators. Landolff Q, et al. Among authors: tarragano f. Arch Cardiovasc Dis. 2022 Oct;115(10):505-513. doi: 10.1016/j.acvd.2022.05.008. Epub 2022 Sep 5. Arch Cardiovasc Dis. 2022. PMID: 36123284 Free article.
11 results